1. Home
  2. Pharma & Healthcare
  3. Global Transdermal Drug Delivery Patches Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Transdermal Drug Delivery Patches Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 154 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Transdermal Drug Delivery Patches market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Transdermal Drug Delivery Patches market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Transdermal Drug Delivery Patches in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Market Snapshot, By Application
Rx Channel
OTC Channel

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
UCB Pharma
Teva Pharmaceutical
Pfizer
Novartis
Nitto Denko
Mylan
Mundipharma
Luye Pharma Group
Johnson & Johnson
IBSA Group
Hisamitsu Pharmaceutical
GSK
Grünenthal
Endo International
Dr Reddy's Laboratories
Chattem
Beijing Tide Pharmaceutical
Bayer

The study objectives of this report are:
To study and analyze the global Transdermal Drug Delivery Patches market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Transdermal Drug Delivery Patches market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Transdermal Drug Delivery Patches manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Transdermal Drug Delivery Patches market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Transdermal Drug Delivery Patches submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Transdermal Drug Delivery Patches are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Transdermal Drug Delivery Patches Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Transdermal Drug Delivery Patches Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Transdermal Drug Delivery Patches

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Transdermal Drug Delivery Patches Sales Channel and Distributors Analysis
3.3.1 Transdermal Drug Delivery Patches Sales Channel
3.3.2 Transdermal Drug Delivery Patches Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Transdermal Drug Delivery Patches Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Transdermal Drug Delivery Patches Type Introduction
4.1.1 Methyl Salicylate-based Patch
4.1.2 Rivastigmine Transdermal Patch
4.1.3 Fentanyl Transdermal Patch
4.1.4 Lidocaine Patch
4.1.5 Diclofenac Patch
4.1.6 Nicotine Transdermal Patch
4.1.7 Others
4.2 Global Transdermal Drug Delivery Patches Sales by Type 2016-2021
4.3 Global Transdermal Drug Delivery Patches Revenue by Type 2016-2021
4.4 Global Transdermal Drug Delivery Patches Price by Type 2016-2021

5 Market Segment: by Application
5.1 Transdermal Drug Delivery Patches Type Introduction
5.1.1 Rx Channel
5.1.2 OTC Channel
5.2 Global Transdermal Drug Delivery Patches Sales by Application 2016-2021
5.3 Global Transdermal Drug Delivery Patches Revenue by Application 2016-2021
5.4 Global Transdermal Drug Delivery Patches Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Transdermal Drug Delivery Patches Market by Region
6.1.1 Global Transdermal Drug Delivery Patches Sales by Regions
6.1.2 Global Transdermal Drug Delivery Patches Revenue by Regions
6.2 North America Transdermal Drug Delivery Patches Market 2016-2021
6.3 Europe Transdermal Drug Delivery Patches Market 2016-2021
6.4 Asia Pacific Transdermal Drug Delivery Patches Market 2016-2021
6.5 South America Transdermal Drug Delivery Patches Market 2016-2021
6.6 Middle East and Africa Transdermal Drug Delivery Patches Market 2016-2021

7 North America
7.1 North America Transdermal Drug Delivery Patches Market by Country 2016-2021
7.1.1 North America Transdermal Drug Delivery Patches Sales by Country
7.1.2 North America Transdermal Drug Delivery Patches Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Transdermal Drug Delivery Patches Market by Country 2016-2021
8.1.1 Europe Transdermal Drug Delivery Patches Sales by Country
8.1.2 Europe Transdermal Drug Delivery Patches Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Transdermal Drug Delivery Patches Market by Country 2016-2021
9.1.1 Asia Pacific Transdermal Drug Delivery Patches Sales by Country
9.1.2 Asia Pacific Transdermal Drug Delivery Patches Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Transdermal Drug Delivery Patches Market by Country 2016-2021
10.1.1 South America Transdermal Drug Delivery Patches Sales by Country
10.1.2 South America Transdermal Drug Delivery Patches Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Transdermal Drug Delivery Patches Market by Country 2016-2021
11.1.1 Middle East and Africa Transdermal Drug Delivery Patches Sales by Country
11.1.2 Middle East and Africa Transdermal Drug Delivery Patches Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 UCB Pharma
12.1.1 UCB Pharma Company Information
12.1.2 UCB Pharma Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.1.3 UCB Pharma Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 UCB Pharma Key Development
12.2 Teva Pharmaceutical
12.2.1 Teva Pharmaceutical Company Information
12.2.2 Teva Pharmaceutical Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.2.3 Teva Pharmaceutical Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Teva Pharmaceutical Key Development
12.3 Pfizer
12.3.1 Pfizer Company Information
12.3.2 Pfizer Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.3.3 Pfizer Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Pfizer Key Development
12.4 Novartis
12.4.1 Novartis Company Information
12.4.2 Novartis Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.4.3 Novartis Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Novartis Key Development
12.5 Nitto Denko
12.5.1 Nitto Denko Company Information
12.5.2 Nitto Denko Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.5.3 Nitto Denko Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Nitto Denko Key Development
12.6 Mylan
12.6.1 Mylan Company Information
12.6.2 Mylan Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.6.3 Mylan Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Mylan Key Development
12.7 Mundipharma
12.7.1 Mundipharma Company Information
12.7.2 Mundipharma Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.7.3 Mundipharma Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Mylan Key Development
12.9 Johnson & Johnson
12.9.1 Johnson & Johnson Company Information
12.9.2 Johnson & Johnson Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.9.3 Johnson & Johnson Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Johnson & Johnson Key Development
12.8 Luye Pharma Group
12.8.1 Luye Pharma Group Company Information
12.8.2 Luye Pharma Group Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.8.3 Luye Pharma Group Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Luye Pharma Group Key Development
12.11 Hisamitsu Pharmaceutical
12.11.1 Hisamitsu Pharmaceutical Company Information
12.11.2 Hisamitsu Pharmaceutical Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.11.3 Hisamitsu Pharmaceutical Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Hisamitsu Pharmaceutical Key Development
12.12 GSK
12.12.1 GSK Company Information
12.12.2 GSK Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.12.3 GSK Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 GSK Key Development
12.13 Grünenthal
12.13.1 Grünenthal Company Information
12.13.2 Grünenthal Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.13.3 Grünenthal Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Grünenthal Key Development
12.14 Endo International
12.14.1 Endo International Company Information
12.14.2 Endo International Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.14.3 Endo International Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Endo International Key Development
12.15 Dr Reddy's Laboratories
12.15.1 Dr Reddy's Laboratories Company Information
12.15.2 Dr Reddy's Laboratories Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
12.15.3 Dr Reddy's Laboratories Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Dr Reddy's Laboratories Key Development
12.17 Beijing Tide Pharmaceutical
12.18 Bayer

13 Global Transdermal Drug Delivery Patches Market Forecast by Region by Type and by Application
13.1 Global Transdermal Drug Delivery Patches Sales, Revenue Forecast 2022-2027
13.2 Global Transdermal Drug Delivery Patches Forecast by Regions
13.2.1 Global Transdermal Drug Delivery Patches Sales Forecast by Region 2022-2027
13.2.2 Global Transdermal Drug Delivery Patches Revenue Forecast by Region 2022-2027
13.3 Global Transdermal Drug Delivery Patches Forecast by Type
13.3.1 Global Transdermal Drug Delivery Patches Sales Forecast by Type 2022-2027
13.3.2 Global Transdermal Drug Delivery Patches Revenue Forecast by Type 2022-2027
13.3.3 Global Transdermal Drug Delivery Patches Price Forecast by Type 2022-2027
13.4 Global Transdermal Drug Delivery Patches Forecast by Application
13.4.1 Global Transdermal Drug Delivery Patches Sales Forecast by Application 2022-2027
13.4.2 Global Transdermal Drug Delivery Patches Revenue Forecast by Application 2022-2027
13.4.3 Global Transdermal Drug Delivery Patches Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Transdermal Drug Delivery Patches Production Specifications
Table 2: Drivers in Transdermal Drug Delivery Patches Market
Table 3: Restraints Transdermal Drug Delivery Patches Market
Table 4: Opportunity in Transdermal Drug Delivery Patches Market
Table 5: Comparion of Alternative and Transdermal Drug Delivery Patches
Table 6: Transdermal Drug Delivery Patches Raw Materials Key Suppliers List
Table 7: Transdermal Drug Delivery Patches Distributors List
Table 8: Transdermal Drug Delivery Patches Major Buyers in Application One
Table 9: Transdermal Drug Delivery Patches Major Buyers in Application Two
Table 10: Transdermal Drug Delivery Patches Major Buyers in Application Three
Table 11: Global Transdermal Drug Delivery Patches Sales (K Units) by Type 2016-2021
Table 12: Global Transdermal Drug Delivery Patches Sales Market Share by Type 2016-2021
Table 13: Global Transdermal Drug Delivery Patches Revenue (Million USD) by Type 2016-2021
Table 14: Global Transdermal Drug Delivery Patches Revenue Market Share by Type 2016-2021
Table 15: Global Transdermal Drug Delivery Patches Price by Type 2016-2021
Table 16: Global Transdermal Drug Delivery Patches Sales (K Units) by Application 2016-2021
Table 17: Global Transdermal Drug Delivery Patches Sales Market Share by Application 2016-2021
Table 18: Global Transdermal Drug Delivery Patches Revenue (Million USD) by Application 2016-2021
Table 19: Global Transdermal Drug Delivery Patches Revenue Market Share by Application 2016-2021
Table 20: Global Transdermal Drug Delivery Patches Price by Application 2016-2021
Table 21: Global Transdermal Drug Delivery Patches Sales (K Units) by Region 2016-2021
Table 22: Global Transdermal Drug Delivery Patches Sales Market Share by Region 2016-2021
Table 23: Global Transdermal Drug Delivery Patches Revenue (Million USD) by Region 2016-2021
Table 24: Global Transdermal Drug Delivery Patches Revenue Market Share by Region 2016-2021
Table 25: North America Transdermal Drug Delivery Patches Sales (K Units) by Country 2016-2021
Table 26: North America Transdermal Drug Delivery Patches Sales Market Share by Country 2016-2021
Table 27: North America Transdermal Drug Delivery Patches Revenue (Million USD) by Country 2016-2021
Table 28: North America Transdermal Drug Delivery Patches Revenue Market Share by Country 2016-2021)
Table 29: Europe Transdermal Drug Delivery Patches Sales (K Units) by Country 2016-2021
Table 30: Europe Transdermal Drug Delivery Patches Sales Market Share by Country 2016-2021
Table 31: Europe Transdermal Drug Delivery Patches Revenue (Million USD) by Country 2016-2021
Table 32: Europe Transdermal Drug Delivery Patches Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Transdermal Drug Delivery Patches Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Transdermal Drug Delivery Patches Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Transdermal Drug Delivery Patches Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Transdermal Drug Delivery Patches Revenue Market Share by Country 2016-2021)
Table 37: South America Transdermal Drug Delivery Patches Sales (K Units) by Country 2016-2021
Table 38: South America Transdermal Drug Delivery Patches Sales Market Share by Country 2016-2021
Table 39: South America Transdermal Drug Delivery Patches Revenue (Million USD) by Country 2016-2021
Table 40: South America Transdermal Drug Delivery Patches Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Transdermal Drug Delivery Patches Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Transdermal Drug Delivery Patches Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Transdermal Drug Delivery Patches Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Transdermal Drug Delivery Patches Revenue Market Share by Country 2016-2021)
Table 45 UCB Pharma Company Information
Table 46 UCB Pharma Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
Table 47 UCB Pharma Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Teva Pharmaceutical Company Information
Table 49 Teva Pharmaceutical Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
Table 50 Teva Pharmaceutical Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Pfizer Company Information
Table 52 Pfizer Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
Table 53 Pfizer Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Novartis Company Information
Table 55 Novartis Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
Table 56 Novartis Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Nitto Denko Company Information
Table 58 Nitto Denko Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
Table 59 Nitto Denko Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Mylan Company Information
Table 61 Mylan Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
Table 62 Mylan Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Mundipharma Company Information
Table 64 Mundipharma Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
Table 65 Mundipharma Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Luye Pharma Group Company Information
Table 67 Luye Pharma Group Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
Table 68 Luye Pharma Group Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Johnson & Johnson Company Information
Table 70 Johnson & Johnson Transdermal Drug Delivery Patches Product Portfolio, Specification and Application
Table 71 Johnson & Johnson Transdermal Drug Delivery Patches Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Transdermal Drug Delivery Patches Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Transdermal Drug Delivery Patches Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Transdermal Drug Delivery Patches Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Transdermal Drug Delivery Patches Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Transdermal Drug Delivery Patches Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Transdermal Drug Delivery Patches Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Transdermal Drug Delivery Patches Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Transdermal Drug Delivery Patches Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Transdermal Drug Delivery Patches Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Transdermal Drug Delivery Patches Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Transdermal Drug Delivery Patches Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Transdermal Drug Delivery Patches Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Transdermal Drug Delivery Patches Picture
Figure 2: Global Transdermal Drug Delivery Patches Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Transdermal Drug Delivery Patches Supply Chain Analysis
Figure 5: Transdermal Drug Delivery Patches Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Methyl Salicylate-based Patch
Figure 7: Product Picture of Rivastigmine Transdermal Patch
Figure 8: Global Transdermal Drug Delivery Patches Sales Market Share by Type, 2020
Figure 9: Global Transdermal Drug Delivery Patches Revenue Market Share by Type, 2020
Figure 10: Transdermal Drug Delivery Patches in Rx Channel
Figure 11: Global Transdermal Drug Delivery Patches Market: Rx Channel 2016-2021
Figure 12: Transdermal Drug Delivery Patches in OTC Channel
Figure 13: Global Transdermal Drug Delivery Patches Market: OTC Channel 2016-2021
Figure 14: Global Transdermal Drug Delivery Patches Sales Market Share by Application, 2020
Figure 15: Global Transdermal Drug Delivery Patches Revenue Market Share by Application, 2020
Figure 16: Global Transdermal Drug Delivery Patches Sales Market Share by Region 2016-2021
Figure 17: Global Transdermal Drug Delivery Patches Revenue Market Share by Region 2016-2021
Figure 18: North America Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 19: North America Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 20: Europe Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 21: Europe Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 24: South America Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 25: South America Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 28: North America Transdermal Drug Delivery Patches Sales Market Share by Country, 2020
Figure 29: North America Transdermal Drug Delivery Patches Revenue Market Share by Country, 2020
Figure 30: United States Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 31: United States Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 32: Canada Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 33: Canada Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 35: Mexico Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 36: Europe Transdermal Drug Delivery Patches Sales Market Share by Country, 2020
Figure 37: Europe Transdermal Drug Delivery Patches Revenue Market Share by Country, 2020
Figure 38: Germany Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 39: Germany Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 40: France Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 41: France Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 42: UK Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 43: UK Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 44: Italy Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 45: Italy Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 46: Russia Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 46: Russia Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 47: Spain Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 48: Spain Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Transdermal Drug Delivery Patches Sales Market Share by Country, 2020
Figure 50: Asia Pacific Transdermal Drug Delivery Patches Revenue Market Share by Country, 2020
Figure 51: China Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 52: China Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 53: Japan Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 54: Japan Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 55: Korea Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 56: Korea Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 59: India Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 60: India Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 61: Australia Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 62: Australia Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 63: South America Transdermal Drug Delivery Patches Sales Market Share by Country, 2020
Figure 64: South America Transdermal Drug Delivery Patches Revenue Market Share by Country, 2020
Figure 65: Brazil Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 66: Brazil Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 68: Argentina Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 70: Colombia Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Transdermal Drug Delivery Patches Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Transdermal Drug Delivery Patches Revenue Market Share by Country, 2020
Figure 73: Turkey Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 74: Turkey Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Transdermal Drug Delivery Patches Sales (K Units) Status 2016-2021
Figure 78: South Africa Transdermal Drug Delivery Patches Revenue (Million USD) Status 2016-2021
Figure 79: UCB Pharma Transdermal Drug Delivery Patches Revenue Market Share Globally (2019-2021)
Figure 80: Teva Pharmaceutical Transdermal Drug Delivery Patches Revenue Market Share Globally (2019-2021)
Figure 81: Pfizer Transdermal Drug Delivery Patches Revenue Market Share Globally (2019-2021)
Figure 82: Novartis Transdermal Drug Delivery Patches Revenue Market Share Globally (2019-2021)
Figure 83: Nitto Denko Transdermal Drug Delivery Patches Revenue Market Share Globally (2019-2021)
Figure 84: Mylan Transdermal Drug Delivery Patches Revenue Market Share Globally (2019-2021)
Figure 85: Mundipharma Transdermal Drug Delivery Patches Revenue Market Share Globally (2019-2021)
Figure 86: Luye Pharma Group Transdermal Drug Delivery Patches Revenue Market Share Globally (2019-2021)
Figure 87: Johnson & Johnson Transdermal Drug Delivery Patches Revenue Market Share Globally (2019-2021)
Figure 88: IBSA Group Transdermal Drug Delivery Patches Revenue Market Share Globally (2019-2021)
Figure 89: Global Transdermal Drug Delivery Patches Sales (K Units) Forecast (2022-2027)
Figure 90: Global Transdermal Drug Delivery Patches Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets